Med-Chemist : "Quintessential Medicinal Chemistry"
Sunday, November 8, 2009
Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103
Antisense Therapeutics completes repeat-dosing toxicology studies for ATL1103
One can see
the products under development...(
by the same co
)
..
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment